Study clarifies doxapram’s physiologic effects in green sea turtles
Bottom line
Doxapram, a respiratory stimulant sometimes used in reptile and sea turtle anesthesia recovery, increased respiratory rate, heart rate, and blood lactate concentration in clinically healthy, rehabilitated juvenile green sea turtles in a randomized crossover study published in the American Journal of Veterinary Research. The study compared intramuscular doxapram with a control treatment and evaluated cardiorespiratory and blood parameters after administration in turtles weighing 2.9 to 7.6 kg. While doxapram is already recognized as a breathing stimulant in reptiles, this report adds species-specific physiologic data for juvenile green sea turtles, a group commonly treated in rehabilitation settings. (merckvetmanual.com)
Why it matters: For veterinary professionals working in wildlife, exotics, anesthesia, or rehabilitation, the findings help clarify what clinicians should expect after IM doxapram in green sea turtles: not just a higher respiratory rate, but also concurrent cardiovascular stimulation and a rise in lactate. That matters when interpreting post-treatment monitoring data, especially in compromised patients where tachycardia or hyperlactatemia could otherwise be read as worsening stress, hypoperfusion, or disease progression. The study also fills a practical evidence gap in sea turtle medicine, where many treatment decisions still rely on extrapolation from other reptiles or case-based experience. (merckvetmanual.com)
What to watch: The next question is whether the same physiologic shifts hold in anesthetized, critically ill, cold-stunned, or debilitated sea turtles, where the clinical risk-benefit calculation for doxapram may look very different. (researchgate.net)
Key facts
- Drug
- Doxapram
- Species
- Juvenile green sea turtles (Chelonia mydas)
- Study design
- Randomized, complete crossover study
- Setting
- Clinically healthy, rehabilitated turtles at a sea turtle rehabilitation center
- Sample weight range
- 2.9 to 7.6 kg
- Treatment
- Intramuscular doxapram versus control
- Key finding
- Increased respiratory rate, heart rate, and blood lactate concentration
- Publication
- American Journal of Veterinary Research
- Study period
- 2023 through 2025
A new American Journal of Veterinary Research study adds species-specific evidence to a familiar but thinly studied tool in reptile anesthesia: intramuscular doxapram. In clinically healthy, rehabilitated juvenile green sea turtles (Chelonia mydas), the drug increased respiratory rate, heart rate, and blood lactate concentration compared with control treatment, giving clinicians a clearer picture of the short-term physiologic response they may see after use. (merckvetmanual.com)
That matters because doxapram has long been used as a respiratory stimulant across veterinary medicine, including reptiles, but sea turtle-specific data have been limited. General reptile anesthesia guidance describes doxapram as a drug that can stimulate breathing after sedation or anesthesia, and sea turtle rescue and rehabilitation references show it has been part of the emergency or peri-anesthetic toolbox in some programs. Still, much of that use has rested on extrapolation, institutional practice, or case experience rather than controlled trials in green sea turtles. (az.research.umich.edu)
According to the study abstract, investigators used a randomized, complete crossover design from 2023 through 2025 with a 24-hour washout period in juvenile turtles under care at a sea turtle rehabilitation center. The turtles, weighing 2.9 to 7.6 kg, received IM doxapram or control treatment, and researchers evaluated respiratory rate, heart rate, venous blood gas variables, electrolytes, glucose, and lactate. The headline finding was that doxapram increased respiratory rate and heart rate, but it also raised blood lactate concentration, an effect that could complicate clinical interpretation in patients already under physiologic strain. (az.research.umich.edu)
The broader clinical backdrop is important. Sea turtle rehabilitation has become increasingly sophisticated, with dedicated programs, veterinary oversight requirements, and growing interest in pharmacology tailored to these species. Recent sea turtle work has expanded evidence on topics such as meloxicam pharmacokinetics, blood culture interpretation, and rehabilitation physiology, but anesthesia-adjacent drug data remain relatively sparse. In that context, even a focused physiologic study like this one can influence how rehabilitation centers build monitoring protocols and drug plans. (pmc.ncbi.nlm.nih.gov)
I didn’t find a standalone institutional press release or published expert commentary specifically reacting to this AJVR paper. But the available background literature points to why the findings will likely resonate with clinicians in the field: respiratory support and recovery remain recurring challenges in reptile and sea turtle care, and doxapram is already recognized as a stimulant of the medullary respiratory center and peripheral chemoreceptors. That makes this study less about introducing a new drug and more about refining expectations around a familiar one, especially its metabolic and cardiovascular effects. (merckvetmanual.com)
Why it matters: For veterinary professionals, the practical takeaway is caution against reading post-doxapram changes too narrowly. A faster respiratory rate may be the intended effect, but a simultaneous increase in heart rate and lactate could muddy assessment in unstable patients, particularly those with trauma, exhaustion, cold stunning, sepsis, or prolonged rehabilitation stress. In those cases, lactate is often part of the clinical picture already, so knowing the drug itself may push that value upward can help teams avoid overinterpreting a single datapoint. The study also supports a more evidence-based approach to exotics and wildlife pharmacology, where species differences can be clinically meaningful. (journals.plos.org)
What to watch: The next step is translation to real-world patients. Clinicians will want to know whether the same effects appear in anesthetized or critically ill turtles, how long the changes persist, whether dose adjustments alter the lactate response, and whether doxapram improves meaningful outcomes such as recovery quality, ventilation, or survival rather than physiologic stimulation alone. Until then, this study gives rehabilitation and anesthesia teams a better baseline for what “expected” looks like after IM doxapram in juvenile green sea turtles. (researchgate.net)